Medavail: Cowen starts coverage with 'outperform' on telepharmacy promise

Medavail Holdings

14/12/2020 11:48

** Cowen starts coverage on health tech co  MDVL.O  with
"outperform" rating
    ** Brokerage says MDVL is uniquely positioned in the market
with its proprietary tech and scalable telepharmacy model
    ** Sets PT of $17/shr, a premium of ~39% to stock's last
close
    ** Sees path to 100% top-line growth through 2022, with
additional upside based on rate of COVID-19 recovery     
    ** Stock down 15.7% this year, as of last close

 (Reporting by Trisha Roy in Bengaluru)
 ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3635;))